Our
Deadly Diabetes Deception
Greed
and dishonest science have promoted a lucrative worldwide epidemic of
diabetes that honesty and good science can quickly reverse by naturally
restoring the body's blood-sugar control mechanism.
Introduction
If you are an American diabetic, your physician will never tell you that
most cases of diabetes are curable. In fact, if you even mention the
"cure" word around him, he will likely become upset and
irrational. His medical school training only allows him to respond to the
word "treatment". For him, the "cure" word does not
exist. Diabetes, in its modern epidemic form, is a curable disease and has
been for at least 40 years. In 2001, the most recent year for which US
figures are posted, 934,550 Americans died from out-of-control symptoms of
this disease.
Your physician will also never tell you that, at one time, strokes, both
ischaemic and haemorrhagic, heart failure due to neuropathy as well as
both ischaemic and haemorrhagic coronary events, obesity, atherosclerosis,
elevated blood pressure, elevated cholesterol, elevated triglycerides,
impotence, retinopathy, renal failure, liver failure, polycystic ovary
syndrome, elevated blood sugar, systemic candida, impaired carbohydrate
metabolism, poor wound healing, impaired fat metabolism, peripheral
neuropathy as well as many more of today's disgraceful epidemic disorders
were once well understood often to be but symptoms of diabetes.
If you contract diabetes and depend upon orthodox medical treatment,
sooner or later you will experience one or more of its symptoms as the
disease rapidly worsens. It is now common practice to refer to these
symptoms as if they were separable, independent diseases with separate,
unrelated treatments provided by competing medical specialists.
It is true that many of these symptoms can and sometimes do result from
other causes; however, it is also true that this fact has been used to
disguise the causative role of diabetes and to justify expensive,
ineffective treatments for these symptoms.
Epidemic Type II diabetes is curable. By the time you get to the end of
this article, you are going to know that. You're going to know why it
isn't routinely being cured. And, you're going to know how to cure it. You
are also probably going to be angry at what a handful of greedy people
have surreptitiously done to the entire orthodox medical community and to
its trusting patients.
The Diabetes Industry
Today's diabetes industry is a massive community that has grown step by
step from its dubious origins in the early 20th century. In the last 80
years it has become enormously successful at shutting out competitive
voices that attempt to point out the fraud involved in modern diabetes
treatment. It has matured into a religion. And, like all religions, it
depends heavily upon the faith of the believer. So successful has it
become that it verges on blasphemy to suggest that, in most cases, the
kindly high priest with the stethoscope draped prominently around his neck
is a charlatan and a fraud. In the large majority of cases, he has never
cured a single case of diabetes in his entire medical career.
The financial and political influence of this medical community has almost
totally subverted the original intent of our regulatory agencies. They
routinely approve death-dealing, ineffective drugs with insufficient
testing. Former commissioner of the FDA, Dr Herbert Ley, in testimony
before a US Senate hearing, commented: "People think the FDA is
protecting them. It isn't. What the FDA is doing and what the public
thinks it's doing are as different as night and day."
The financial and political influence of this medical community dominates
our entire medical insurance industry. Although this is beginning to
change, in America it is still difficult to find employer group medical
insurance to cover effective alternative medical treatments. Orthodox
coverage is standard in all states. Alternative medicine is not. For
example, there are only 1,400 licensed naturopaths in 11 states compared
to over 3.4 million orthodox licensees in 50 states. Generally, only
approved treatments from licensed, credentialled practitioners are
insurable. This, in effect, neatly creates a special kind of money that
can only be spent within the orthodox medical and drug industry. No other
industry in the world has been able to manage the politics of convincing
people to accept so large a part of their pay in a form that often does
not allow them to spend it as they see fit.
The financial and political influence of this medical community completely
controls virtually every diabetes publication in the country. Many
diabetes publications are subsidised by ads for diabetes supplies. No
diabetes editor is going to allow the truth to be printed in his magazine.
This is why the diabetic only pays about one-quarter to one-third of the
cost of printing the magazine he depends upon for accurate information.
The rest is subsidised by diabetes manufacturers with a vested commercial
interest in preventing diabetics from curing their diabetes. When looking
for a magazine that tells the truth about diabetes, look first to see if
it is full of ads for diabetes supplies.
And then there are the various associations that solicit annual donations
to find a cure for their proprietary disease. Every year they promise that
a cure is just around the corner—just send more money! Some of these
very same associations have been clearly implicated in providing advice
that promotes the progress of diabetes in their trusting supporters. For
example, for years they heavily promoted exchange diets,
which are in fact scientifically worthless—as anyone who has ever
tried to use them quickly finds out. They ridiculed the use of glycemic
tables, which are actually very helpful to the diabetic. They promoted the
use of margarine as heart healthy, long after it was well understood that margarine
causes diabetes and promotes heart failure.
If people ever wake up to the cure for diabetes that has been suppressed
for 40 years, these associations will soon be out of business. But until
then, they nonetheless continue to need our support. For 40 years, medical
research has consistently shown with increasing clarity that diabetes is a
degenerative disease directly caused by an
engineered food supply that is focused on profit instead of health.
Although the diligent can readily glean this information from a wealth of
medical research literature, it is generally otherwise unavailable.
Certainly this information has been, and remains, largely unavailable in
the medical schools that train our retail doctors.
Prominent among the causative agents in our modern diabetes epidemic are
the engineered fats and oils that are sold in today's supermarkets.The
first step to curing diabetes is to stop believing the lie that the
disease is incurable.
Diabetes
History
In 1922, three Canadian Nobel Prize winners, Banting, Best and Macleod,
were successful in saving the life of a fourteen-year-old diabetic girl in
Toronto General Hospital with injectable insulin. Eli Lilly was licensed
to manufacture this new wonder drug, and the medical community basked in
the glory of a job well done.
It wasn't until 1933 that rumours about a new rogue form of diabetes
surfaced. This was in a paper presented by Joslyn, Dublin and Marks and
printed in the American Journal of Medical Sciences. This paper,
"Studies on Diabetes Mellitus",
discussed the emergence of a major epidemic of a disease
which looked very much like the diabetes of the early 1920s, only it did
not respond to the wonder drug, insulin. Even worse, sometimes
insulin treatment killed the patient.
This new disease became known as "insulin-resistant diabetes"
because it had the elevated blood sugar symptom of diabetes but responded
poorly to insulin therapy. Many physicians had considerable success in
treating this disease through diet. A great deal was learned about the
relationship between diet and diabetes in the 1930s and 1940s.
Diabetes, which had a per-capita incidence of 0.0028% at the turn of the
century, had by 1933 zoomed 1,000% in the United States to become a
disease seen by many doctors.This disease, under a variety of aliases, was
destined to go on to wreck the health of
over half the American population and incapacitate almost
20% by the 1990s.
In 1950, the medical community became able to perform serum
insulin assays. These assays quickly revealed that
this new disease wasn't classic diabetes; it was characterised by
sufficient, often excessive, blood insulin levels. The problem was that
the insulin was ineffective; it did not reduce blood sugar. But since the
disease had been known as diabetes for almost 20 years, it was renamed
Type II diabetes. This was to distinguish it from the earlier Type I
diabetes, caused by insufficient insulin production by the pancreas. Had
the dietary insights of the previous 20 years dominated the medical scene
from this point and into the late 1960s, diabetes would have become widely
recognised as curable instead of merely treatable. Instead, in 1950, a
search was launched for another wonder drug to deal with the Type II
diabetes problem.
Cure
versus Treatment
This new, ideal, wonder drug would be effective, like insulin, in
remitting obvious adverse symptoms of the disease but not effective in
curing the underlying disease. Thus it would be needed continually for the
remaining life of the patient. It would have to be patentable; that is, it
could not be a natural medication because these are non-patentable. Like
insulin, it would have to be highly profitable to manufacture and
distribute. Mandatory government approvals would be required to stimulate
physicians to prescribe it as a prescription drug. Testing required for
these approvals would have to be enormously expensive to prevent other,
unapproved, medications from becoming competitive.
This is the origin of the classic medical protocol of "treating the
symptoms". By doing this, both the drug company and the doctor could
prosper in business, and the patient, while not being cured of his
disease, was sometimes temporarily relieved
of some of his symptoms.
Additionally, natural medications that actually cured disease would have
to be suppressed. The more effective they were, the more they would need
to be suppressed and their proponents jailed as quacks. After all, it
wouldn't do to have some cheap, effective, natural medication cure disease
in a capital-intensive monopoly market specifically designed to treat
symptoms without curing disease. Often the natural substance really did
cure disease. This is why the force of law has been and is being used to
drive the natural, often superior, medicines from the marketplace, to
remove the "cure" word from the medical vocabulary and to
undermine totally the very concept of a free marketplace in the medical
business.
Now it is clear why the "cure" word is so vigorously suppressed
by law. The FDA has extensive Orwellian regulations that prohibit the use
of the "cure" word to describe any competing medicine or natural
substance. It is precisely because many natural substances do actually
both cure and prevent disease that this word has become so frightening to
the drug and orthodox medical community.
The
Commercial Value of Symptoms
After the drug development policy was redesigned to focus on ameliorating
symptoms rather than curing disease, it became necessary to reinvent the
way drugs were marketed. This was done in 1949 in the midst of a major
epidemic of insulin-resistant diabetes.
So, in 1949, the US medical community reclassified the symptoms of
diabetes along with many other disease symptoms into diseases in their own
right. With this reclassification as the new basis for diagnosis,
competing medical speciality groups quickly seized upon related groups of
symptoms as their own proprietary symptoms set.
Thus the heart specialist, endocrinologist, allergist, kidney specialist
and many others started to treat the symptoms for which they felt
responsible. As the underlying cause of the disease was widely ignored,
all focus on actually curing anything was completely lost.
Heart failure, for example, which had previously been understood
often to be but a symptom of diabetes, now became a disease not directly
connected to diabetes. It became fashionable to think that diabetes
"increased cardiovascular risk". The causal role of a failed
blood-sugar control system in heart failure became obscured.
Consistent with the new medical paradigm, none of the treatments offered
by the heart specialist actually cures, or is even intended to cure, their
proprietary disease. For example, the
three-year survival rate for bypass surgery is almost exactly the same as
if no surgery was undertaken.
Today, over half of the people in America suffer from one or more symptoms
of this disease. In its beginnings, it became well known to physicians as
Type II diabetes, insulin-resistant diabetes, insulin resistance,
adult-onset diabetes or, more rarely, hyperinsulinaemia. According to the
American Heart Association, almost 50% of Americans suffer from one or
more symptoms of this disease. One third of
the US population is morbidly obese; half
of the population is overweight. Type II diabetes, also
called adult-onset diabetes, now appears routinely in six-year-old
children.
Many degenerative diseases can be traced to a massive failure of the
endocrine system. This was well known to the physicians of the 1930s as
insulin-resistant diabetes. This basic underlying disorder is known to be
a derangement of the blood-sugar control system by
badly engineered fats and oils. It is exacerbated and
complicated by the widespread lack of other essential nutrition that the
body needs to cope with the metabolic consequences of these poisons.
All fats and oils are not equal. Some are healthy and beneficial; many,
commonly available in the supermarket, are poisonous. The
health distinction is not between saturated and unsaturated, as the fats
and oils industry would have us believe. Many saturated oils and fats are
highly beneficial; many unsaturated oils are
highly poisonous. The important
health distinction is between natural and engineered.
There exists great dishonesty in advertising in the fats and oils
industry. It is aimed at creating a market for cheap junk oils such as soy,
cottonseed and rapeseed oils. With
an informed and aware public, these oils would have no market at all, and
the USA—indeed, the world—would have far fewer cases of diabetes.
Epidemiological Lifestyle Link
As early as 1901, efforts had been made to manufacture and sell food
products by the use of automated factory machinery because of the immense
profits that were possible. Most of the early efforts failed because
people were inherently suspicious of food that wasn't farm fresh and
because the technology was poor. As long as people were prosperous,
suspicious food products made little headway. Crisco,
the artificial shortening, was once given away free in 21⁄2 lb cans
in an unsuccessful effort to influence American housewives to trust and
buy the product in preference to lard.
Margarine
was introduced and was bitterly opposed by the dairy states in the USA.
With the advent of the Depression of the 1930s, margarine, Crisco and a
host of other refined and hydrogenated products began to make significant
penetration into the food markets of America. Support for dairy opposition
to margarine faded during World War II because there wasn't enough butter
for the needs of both the civilian population and the military.
At this point, the dairy industry, having lost much support,
simply accepted a diluted market share and concentrated on supplying the
military.
Flax
oils and fish oils, which were common in the stores
and considered dietary staples before the American population became
diseased, have disappeared from the shelf. The last supplier of flax oil
to the major distribution chains was Archer Daniels Midland, and it
stopped producing and supplying the product in 1950.
More recently, one of the most important of the remaining, genuinely
beneficial, fats was subjected to a massive media disinformation campaign
that portrayed it as a saturated fat that causes heart failure. As a
result, it has virtually disappeared from the supermarket shelves. Thus
was coconut
oil removed from the food chain and replaced with soy
oil, cottonseed
oil and rapeseed
oil. Our parents and grandparents would never have
swapped a fine, healthy oil like coconut oil for these cheap, junk oils.
It was shortly after this successful media blitz that the US populace lost
its war on fat. For many years, coconut oil had been our most effective
dietary weight-control agent.
The history of the engineered adulteration of our once-clean food supply
exactly parallels the rise of the epidemic of diabetes and
hyperinsulinaemia now sweeping the United States as well as much of the
rest of the world. The
second step to a cure for this disease epidemic is to stop believing the
lie that our food supply is safe and nutritious.
The
Nature of the Disease
Diabetes is classically diagnosed as a failure of the body to metabolise
carbohydrates properly. Its defining symptom is a high blood-glucose
level. Type I diabetes results from insufficient insulin production by the
pancreas. Type II diabetes results from ineffective insulin. In both
types, the blood-glucose level remains elevated. Neither insufficient
insulin nor ineffective insulin can limit post-prandial (after-eating)
blood sugar to the normal range. In established cases of Type II diabetes,
these elevated blood sugar levels are often preceded and accompanied by
chronically elevated insulin levels and by serious distortions of other
endocrine hormonal markers.
The ineffective insulin is no different from effective insulin. Its
ineffectiveness lies in the failure of the cell population to respond to
it. It is not the result of any biochemical defect in the insulin itself.
Therefore, it is appropriate to note that this is a disease that affects
almost every cell in the 70 trillion or so cells of the body. All of these
cells are dependent upon the food that we eat for the raw materials they
need for self repair and maintenance.
The classification of diabetes as a failure to metabolise carbohydrates is
a traditional classification that originated in the early 19th century
when little was known about metabolic diseases or processes.
Today, with our increased knowledge of these processes, it would
appear quite appropriate to define Type II diabetes more fundamentally as
a failure of the body to metabolise fats and oils properly. This failure
results in a loss of effectiveness of insulin and in the consequent
failure to metabolise carbohydrates. Unfortunately, much medical insight
into this matter, except at the research level, remains hampered by its
19th-century legacy.
Thus Type II diabetes and its early hyperinsulinaemic symptoms are
whole-body symptoms of this basic cellular failure to metabolise glucose
properly. Each cell of the body, for reasons which are becoming clearer,
finds itself unable to transport glucose from the bloodstream to its
interior. The glucose then remains in the bloodstream, or is stored as
body fat or as glycogen, or is otherwise disposed of in urine.
It appears that when insulin binds to a cell membrane receptor, it
initiates a complex cascade of biochemical reactions inside the cell. This
causes a class of glucose transporters known as GLUT4 molecules to leave
their parking area inside the cell and travel to the inside surface of the
plasma cell membrane.
When in the membrane, they migrate to special areas of the membrane called
caveolae areas. There, by another series of biochemical reactions, they
identify and hook up with glucose molecules and transport them into the
interior of the cell by a process called endocytosis. Within the cell's
interior, this glucose is then burned as fuel by the mitochondria to
produce energy to power cellular activity. Thus these GLUT4 transporters
lower glucose in the bloodstream by transporting it out of the bloodstream
into all the cells of the body.
Many of the molecules involved in these glucose- and insulin-mediated
pathways are lipids; that is, they are fatty acids. A healthy plasma cell
membrane, now known to be an active player in the glucose scenario,
contains a complement of cis-type w=3 unsaturated fatty acids. This makes
the membrane relatively fluid and slippery. When these cis- fatty acids
are chronically unavailable because of our diet, trans- fatty acids and
short- and medium-chain saturated fatty acids are substituted in the cell
membrane. These substitutions make the cellular membrane stiffer and more
sticky, and inhibit the glucose transport mechanism.
Thus, in the absence of sufficient cis
omega 3 fatty acids in our diet, these fatty acid
substitutions take place, the mobility of the GLUT4 transporters is
diminished, the interior biochemistry of the cell is changed and glucose
remains elevated in the bloodstream. Elsewhere
in the body, the pancreas secretes excess insulin, the liver manufactures
fat from the excess sugar, the adipose cells store excess fat, the body
goes into a high urinary mode, insufficient cellular energy is available
for bodily activity and the entire endocrine system becomes distorted.
Eventually, pancreatic failure occurs, body weight plummets and a diabetic
crisis is precipitated.
Although there remains much work to be done to elucidate fully all of the
steps in all of these pathways, this clearly marks the beginning of a
biochemical explanation for the known epidemiological relationship between
cheap, engineered dietary fats and oils and the onset of Type II diabetes.
Orthodox
Medical Treatment
After the diagnosis of diabetes, modern orthodox medical treatment
consists of either oral hypoglycaemic agents or insulin.
•
Oral hypoglycaemic agents
In 1955, oral
hypoglycaemic drugs were introduced. Currently
available oral hypoglycaemic agents fall into five classifications
according to their biophysical mode of action. These classes are:
biguanides; glucosidase inhibitors; meglitinides; sulphonylureas; and
thiazolidinediones. The biguanides
lower blood sugar in three ways. They inhibit the normal release by the
liver of its glucose stores, they interfere with intestinal absorption of
glucose from ingested carbohydrates, and they are said to increase
peripheral uptake of glucose.
The glucosidase inhibitors are designed to inhibit the amylase enzymes
produced by the pancreas and which are essential to the digestion of
carbohydrates. The theory is that if the digestion of carbohydrates is
inhibited, the blood sugar level cannot be elevated.
The meglitinides are designed to stimulate the pancreas to produce
insulin in a patient that likely already has an elevated level of insulin
in their bloodstream. Only rarely does the doctor even measure the insulin
level. Indeed, these drugs are frequently prescribed without any knowledge
of the pre-existing insulin level. The fact that an elevated insulin level
is almost as damaging as an elevated glucose level is widely ignored.
The sulphonylureas are another pancreatic stimulant class designed to
stimulate the production of insulin. Serum insulin determinations are
rarely made by the doctor before he prescribes these drugs. They are often
prescribed for Type II diabetics, many of whom already have elevated
ineffective insulin. These drugs are notorious for causing hypoglycaemia
as a side effect.
The thiazolidinediones are famous for causing liver cancer. One of them, Rezulin,
was approved in the USA through devious political infighting, but failed
to get approval in the UK because it was known to cause liver cancer. The
doctor who had responsibility to approve it at the FDA refused to do so.
It was only after he was replaced by a more compliant official that Rezulin
gained approval by the FDA. It went on to kill well over 100 diabetes
patients and cripple many others before the fight to get it off the market
was finally won. Rezulin
was designed to stimulate the uptake of glucose from the bloodstream by
the peripheral cells and to inhibit the normal secretion of glucose by the
liver. The politics of why this drug ever came onto market, and then
remained in the market for such an unexplainable length of time with
regulatory agency approval, is not clear.
As of April 2000, lawsuits commenced to clarify this situation.
•
Insulin
Today, insulin is prescribed for both the Type I and Type
II diabetics. Injectable insulin substitutes for the insulin that the body
no longer produces. Of course, this treatment, while necessary for
preserving the life of the Type I diabetic, is highly questionable when
applied to the Type II diabetic. It
is important to note that neither insulin nor any of these oral
hypoglycaemic agents exerts any curative action whatsoever on any type of
diabetes. None of these medical strategies is designed to normalise the
cellular uptake of glucose by the cells that need it to power their
activity.
The prognosis with this orthodox treatment is increasing disability and
early death from heart or kidney failure or the failure of some other
vital organ.
Alternative
Medical Treatment
The third step to a cure for this disease is to become informed and to
apply an alternative methodology that is soundly based upon good science.
Effective alternative treatment that directly leads to a cure is
available today for some Type I and for many Type II diabetics. About 5%
of the diabetic population suffers from Type I diabetes; about 95% has
Type II diabetes. Gestational
diabetes is simply ordinary diabetes contracted by a woman who is
pregnant.
For the Type I diabetic, an alternative methodology for the treatment of
Type I diabetes is now available. It was developed in modern hospitals in
Madras, India, and subjected to rigorous double-blind studies to prove its
efficacy. It operates to restore normal pancreatic beta cell function so
that the pancreas can again produce insulin as it should. This approach
apparently was capable of curing Type I diabetes in over 60% of the
patients on whom it was tested. The major complication lies in whether the
antigens that originally led to the autoimmune destruction of these beta
cells have disappeared from or remain in the body. If they remain, a cure
is less likely; if they have disappeared, the cure is more likely. For
reasons already discussed, this methodology is not likely to appear in the
United States any time soon, and certainly not in the American orthodox
medical community.
The goal of any effective alternative program is to repair and restore the
body's own blood-sugar control mechanism. It is the malfunctioning of this
mechanism that, over time, directly causes all of the many debilitating
symptoms that make orthodox treatment so financially rewarding for the
diabetes industry. For Type II diabetes, the steps in the program are:
•
Repair the faulty blood sugar control system. This is done simply
by substituting clean, healthy, beneficial fats and oils in the diet for
the pristine-looking but toxic trans-isomer mix found in attractive
plastic containers on supermarket shelves. Consume only flax oil, fish oil
and occasionally cod liver oil until blood sugar starts to stabilise. Then
add back healthy oils such as butter, coconut oil, olive oil and clean
animal fat. Read labels; refuse to consume cheap junk oils when they
appear in processed food or on restaurant menus. Diabetics are chronically
short of minerals; they need to add a good-quality, broad-spectrum mineral
supplement to the diet.
•
Control blood sugar manually during the recovery cycle.
Under medical supervision, gradually discontinue all oral hypoglycaemic
agents along with any additional drugs given to counteract their side
effects. Develop natural blood-sugar control by the use of glycaemic
tables, by consuming frequent small meals (including fibre-rich foods),
by regular post-prandial exercise, and by the complete avoidance of all
sugars along with the judicious use of only non-toxic sweeteners.
Avoid alcohol until blood sugar
stabilises in the normal range. Keep score by using a
pinprick-type glucose meter. Keep track of everything you do with a
medical diary.
•
Restore a proper balance of healthy fats and oils when the
blood sugar controller again works. Permanently remove from the diet all
cheap, toxic, junk fats and oils as well
as the processed and restaurant foods that contain them.
When the blood sugar controller again starts to work correctly, gradually
introduce additional healthy foods to the diet. Test the effect of these
added foods by monitoring blood sugar levels with the pinprick-type blood
sugar monitor. Be sure to include the results of these tests in your diary
also.
•
Continue the program until normal insulin values are also
restored after blood sugar levels begin to stabilise in the normal region.
Once blood sugar levels fall into the normal range, the pancreas will
gradually stop overproducing insulin. This process will typically take a
little longer and can be tested by having your physician send a sample of
your blood to a lab for a serum insulin determination. A good idea is to
wait a couple of months after blood sugar control is restored and then
have your physician check your insulin level. It's nice to have blood
sugar in the normal range; it's even nicer to have this accomplished
without excess insulin in the bloodstream.
•
Separately repair the collateral damage done by the disease. Vascular
problems caused by a chronically elevated glucose level will normally
reverse themselves without conscious effort. The effects of retinopathy
and of peripheral neuropathy, for example, will usually self repair.
However, when the fine capillaries in the basement membranes of the
kidneys begin to leak due to chronic high blood glucose, the kidneys
compensate by laying down scar tissue to prevent the leakage. This scar
tissue remains even after the diabetes is cured, and is the reason why the
kidney damage is not believed to self repair.
A word of warning…
When retinopathy
develops, there may be a temptation to have the damage repaired by laser
surgery. This laser technique stops the retinal bleeding by creating scar
tissue where the leaks have developed. This scar tissue will prevent
normal healing of the fine capillaries in the eye when the diabetes is
reversed. By reversing the diabetes instead of opting for laser surgery,
there is an excellent chance that the eye will heal completely. However,
if laser surgery is done, this healing will always be complicated by the
scar tissue left by the laser. The
arterial and vascular damage done by years of elevated sugar and insulin
and by the proliferation of systemic candida will slowly reverse due to
improved diet. However, it takes many years to clean out the arteries by
this form of oral chelation. Arterial damage can be reversed much more
quickly by using intravenous chelation therapy. What would normally take
many years through diet alone can often be done in six months with
intravenous therapy. This is reputed to be effective over 80% of the time.
For obvious reasons, don't expect your doctor to approve of this,
particularly if he's a heart specialist.
Recovery
Time
The prognosis is usually swift recovery from the disease and restoration
of normal health and energy levels in a few months to a year or more. The
length of time that it takes to effect a cure depends upon how long the
disease was allowed to develop. For those who work quickly to reverse the
disease after early discovery, the time is usually a few months or less.
For those who have had the disease for many years, this recovery time may
lengthen to a year or more. Thus, there is good reason to get busy
reversing this disease as soon as it becomes clearly identified.
By the time you get to this point in this article, and if we've done a
good job of explaining our diabetes epidemic, you should know what causes
it, what orthodox medical treatment is all about, and why diabetes has
become a national and international disgrace. Of even greater importance,
you have become acquainted with a self-help program that has demonstrated
great potential to actually cure this disease. ∞
About the
Author:
Thomas Smith is a reluctant medical investigator, having been forced into
curing his own diabetes because it was obvious that his doctor would not
or could not cure it. He has published the results of his successful
diabetes investigation in his self-help manual, Insulin: Our Silent
Killer, written for the layperson but also widely valued by the medical
practitioner. This manual details the steps required to reverse Type II
diabetes and references the work being done with Type I diabetes. The book
may be purchased from the author at PO Box 7685, Loveland, Colorado 80537,
USA (North American residents send $US25.00; overseas residents should
contact the author for payment and shipping instructions).
Thomas Smith has also posted a great deal of useful information about
diabetes on his website, http://www.Healingmatters.
com. He can be contacted by telephone at +1 (970) 669 9176 and by email at
valley@healingmatters.com.
Endnotes:
1. National Center for Health Statistics, "Fast Stats",
Deaths/Mortality Preliminary 2001 data
2. Dr Herbert Ley, in response to a question from Senator Edward Long
about the FDA during US Senate hearings in 1965
3. Eisenberg, David M., MD, "Credentialing complementary and
alternative medical providers", Annals of Internal Medicine
137(12):968 (December 17, 2002)
4. American Diabetes Association and the American Dietetic Association,
The Official Pocket Guide to Diabetic Exchanges, McGraw-Hill/Contemporary
Distributed Products, newly updated March 1, 1998
5. American Heart Association, "How Do I Follow a Healthy
Diet?", American Heart Association
National Center (7272 Greenville Avenue, Dallas, Texas 75231-4596, USA), http://www.americanheart.org
6. Brown., J.A.C., Pears Medical Encyclopedia Illustrated, 1971, p. 250
7. Joslyn, E.P., Dublin, L.I., Marks, H.H., "Studies on Diabetes
Mellitus", American Journal of Medical Sciences 186:753-773 (1933)
8. "Diabetes Mellitus", Encyclopedia Americana, Library Edition,
vol. 9, 1966, pp. 54-56
9. American Heart Association, "Stroke (Brain Attack)", August
28, 1998, http://www.amhrt.org/ScientificHStats98/05stroke.html;
American Heart Association, "Cardiovascular Disease Statistics",
August 28, 1998, http://www.amhrt.org/Heart_and_Stroke_A_Z_Guide/cvds.html;
"Statistics related to overweight and obesity",
http://niddk.nih.gov/health/nutrit/pubs/statobes.htm;
http://www.winltdusa.com/about/infocenter/
healthnews/articles/obesestats.htm
10. "Diabetes Mellitus", Encyclopedia Americana, ibid., pp.
54-55
11. The Veterans Administration Coronary Artery Bypass Co-operative Study
Group, "Eleven-year survival in the Veterans Administration
randomized trial of coronary bypass surgery for stable angina", New
Eng. J. Med. 311:1333-1339 (1984); Coronary Artery Surgery Study (CASS),
"A randomized trial of coronary artery bypass surgery: quality of
life in patients randomly assigned to treatment groups", Circulation
68(5):951-960 (1983)
12. Trager, J., The Food Chronology, Henry Holt & Company, New York,
1995 (items listed by date)
13. "Margarine", Encyclopedia Americana, Library Edition, vol.
9, 1966, pp. 279-280
14. Fallon, S., Connolly, P., Enig, M.C., Nourishing Traditions, Promotion
Publishing, 1995;
Enig, M.C., "Coconut: In Support of Good Health in the 21st
Century", http://www.livecoconutoil.com/maryenig.htm
15. Houssay, Bernardo, A., MD, et al., Human Physiology, McGraw-Hill Book
Company, 1955, pp. 400-421
16. Gustavson, J., et al., "Insulin-stimulated glucose uptake
involves the transition of glucose transporters to a caveolae-rich
fraction within the plasma cell membrane: implications for type II
diabetes", Mol. Med. 2(3):367-372 (May 1996)
17. Ganong, William F., MD, Review of Medical Physiology, 19th edition,
1999, p. 9, pp. 26-33
18. Pan, D.A. et al., "Skeletal muscle membrane lipid composition is
related to adiposity and insulin action", J. Clin. Invest.
96(6):2802-2808 (December 1995)
19. Physicians' Desk Reference, 53rd edition, 1999
20. Smith, Thomas, Insulin: Our Silent Killer, Thomas Smith, Loveland,
Colorado, revised 2nd
edition, July 2000, p. 20
21. Law Offices of Charles H. Johnson & Associates (telephone 1 800
535 5727, toll free in North America)
22. American Heart Association, "Diabetes Mellitus Statistics", http://www.amhrt.org
23. Shanmugasundaram, E.R.B. et al. (Dr Ambedkar Institute of Diabetes,
Kilpauk Medical College Hospital, Madras, India), "Possible
regeneration of the Islets of Langerhans in Streptozotocin-diabetic rats
given Gymnema sylvestre leaf extract", J. Ethnopharmacology
30:265-279 (1990);
Shanmugasundaram, E.R.B. et al., "Use of Gemnema sylvestre leaf
extract in the control of blood glucose in insulin-dependent diabetes
mellitus", J. Ethnopharmacology 30:281-294 (1990)
24. Smith, ibid., pp. 97-123
25. Many popular artificial sweeteners on sale in the supermarket are
extremely poisonous and dangerous to the diabetic; indeed, many of them
are worse than the sugar the diabetic is trying to avoid; see, for
example, Smith, ibid., pp. 53-58.
26. Walker, Morton, MD, and Shah, Hitendra, MD, Chelation Therapy, Keats
Publishing, Inc., New Canaan, Connecticut, 1997, ISBN 0-87983-730-6